COMP <GO>
XPEV vs AMZN // ALTMAN Z-SCORE & DEBT/EQUITY
XPeng Inc. American (NYSE) VS. Amazon.com, Inc. (NASDAQ) • 15-METRIC TALLY: XPEV 4
— AMZN 6
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: XPEV
LAST: $9.04 (-1.53%) • MKT CAP: $8.80B
balance-sheet
3.74
LAST: $240.35 (-1.41%) • MKT CAP: $2.59T
balance-sheet
3.32
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XPEV VS. AMZN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | XPEV | AMZN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | 17.61% | -7.71 | AMZN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.0x | 15.8x | +5.25 | AMZN | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | -1.81% | +4.02 | XPEV | /fcf-yield <GO> |
| Operating Margin | 13.90% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 10.90% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 6.60% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 3.74 | 3.32 | +0.42 | XPEV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | XPEV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.73% | +0.27 | AMZN | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.4 | 38.3 | +1.12 | XPEV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.03 | 1.46 | -0.43 | AMZN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.5x | 22.8x | +7.75 | AMZN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $8.80B | $2.59T | -$2.58T | AMZN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | XPEV REV | AMZN REV | XPEV GROSS % | AMZN GROSS % | XPEV FCF | AMZN FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $0 | — | — | — | -$46.89B |
| FY 2025 | — | $0 | — | — | — | $10.56B |
| FY 2024 | — | $0 | — | — | — | $42.95B |
| FY 2023 | — | $0 | — | — | — | $16.92B |
| FY 2022 | — | $0 | — | — | — | -$26.32B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XPEV // BETA 1.03
AMZN // BETA 1.46